annual retained earnings:
$7.94B-$1.25B(-13.61%)Summary
- As of today (August 17, 2025), TAK annual retained earnings is $7.94 billion, with the most recent change of -$1.25 billion (-13.61%) on March 1, 2025.
- During the last 3 years, TAK annual retained earnings has fallen by -$4.25 billion (-34.86%).
- TAK annual retained earnings is now -71.03% below its all-time high of $27.41 billion, reached on March 31, 2011.
Performance
TAK Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
$8.00B+$65.36M(+0.82%)Summary
- As of today (August 17, 2025), TAK quarterly retained earnings is $8.00 billion, with the most recent change of +$65.36 million (+0.82%) on June 1, 2025.
- Over the past year, TAK quarterly retained earnings has dropped by -$313.53 million (-3.77%).
- TAK quarterly retained earnings is now -73.72% below its all-time high of $30.45 billion, reached on September 30, 2011.
Performance
TAK quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
TAK Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.6% | -3.8% |
| 3 y3 years | -34.9% | -25.1% |
| 5 y5 years | -37.4% | -35.3% |
TAK Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -34.9% | at low | -30.8% | +0.8% |
| 5 y | 5-year | -41.9% | at low | -42.3% | +0.8% |
| alltime | all time | -71.0% | +166.4% | -73.7% | +0.8% |
TAK Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $8.00B(+0.8%) |
| Mar 2025 | $7.94B(-13.6%) | $7.94B(-3.5%) |
| Dec 2024 | - | $8.22B(-18.0%) |
| Sep 2024 | - | $10.02B(+20.6%) |
| Jun 2024 | - | $8.32B(-9.5%) |
| Mar 2024 | $9.19B(-20.6%) | $9.19B(-7.2%) |
| Dec 2023 | - | $9.90B(+2.3%) |
| Sep 2023 | - | $9.68B(-5.9%) |
| Jun 2023 | - | $10.29B(-11.0%) |
| Mar 2023 | $11.58B(-5.0%) | $11.57B(+0.6%) |
| Dec 2022 | - | $11.50B(+8.6%) |
| Sep 2022 | - | $10.59B(-0.9%) |
| Jun 2022 | - | $10.69B(-11.8%) |
| Mar 2022 | $12.19B(-10.8%) | $12.12B(-4.9%) |
| Dec 2021 | - | $12.75B(-8.0%) |
| Sep 2021 | - | $13.86B(+1.9%) |
| Jun 2021 | - | $13.60B(-0.6%) |
| Mar 2021 | $13.66B(+7.7%) | $13.69B(+8.0%) |
| Dec 2020 | - | $12.67B(+0.1%) |
| Sep 2020 | - | $12.65B(+2.4%) |
| Jun 2020 | - | $12.36B(-2.5%) |
| Mar 2020 | $12.69B(-12.0%) | $12.68B(+0.1%) |
| Dec 2019 | - | $12.66B(-7.5%) |
| Sep 2019 | - | $13.69B(+5.1%) |
| Jun 2019 | - | $13.02B(-9.5%) |
| Mar 2019 | $14.41B(-1.6%) | $14.39B(-1.7%) |
| Dec 2018 | - | $14.63B(+0.9%) |
| Sep 2018 | - | $14.50B(+0.6%) |
| Jun 2018 | - | $14.42B(-1.6%) |
| Mar 2018 | $14.64B(+7.9%) | $14.65B(+2.6%) |
| Dec 2017 | - | $14.28B(-0.5%) |
| Sep 2017 | - | $14.35B(+1.3%) |
| Jun 2017 | - | $14.16B(+4.7%) |
| Mar 2017 | $13.57B(+0.1%) | $13.52B(+1.7%) |
| Dec 2016 | - | $13.30B(-14.4%) |
| Sep 2016 | - | $15.55B(+3.1%) |
| Jun 2016 | - | $15.08B(+11.3%) |
| Mar 2016 | $13.55B(+1.5%) | $13.55B(+3.2%) |
| Dec 2015 | - | $13.13B(-1.2%) |
| Sep 2015 | - | $13.29B(+4.4%) |
| Jun 2015 | - | $12.73B(-4.6%) |
| Mar 2015 | $13.35B | $13.34B(-12.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | - | $15.28B(-11.1%) |
| Sep 2014 | - | $17.18B(-6.0%) |
| Jun 2014 | - | $18.27B(-1.1%) |
| Mar 2014 | $18.46B(-10.0%) | $18.48B(-12.4%) |
| Dec 2013 | - | $21.08B(-7.8%) |
| Sep 2013 | - | $22.86B(+2.3%) |
| Jun 2013 | - | $22.35B(+9.2%) |
| Mar 2013 | $20.50B(-25.1%) | $20.47B(-21.8%) |
| Dec 2012 | - | $26.18B(-11.7%) |
| Sep 2012 | - | $29.66B(+3.7%) |
| Jun 2012 | - | $28.61B(+22.6%) |
| Mar 2012 | $27.39B(-0.1%) | $23.33B(-20.8%) |
| Dec 2011 | - | $29.48B(-3.2%) |
| Sep 2011 | - | $30.45B(+7.9%) |
| Jun 2011 | - | $28.21B(+3.3%) |
| Mar 2011 | $27.41B(+18.2%) | $27.31B(-0.6%) |
| Dec 2010 | - | $27.48B(+2.9%) |
| Sep 2010 | - | $26.72B(+9.5%) |
| Jun 2010 | - | $24.40B(+5.4%) |
| Mar 2010 | $23.18B(+13.8%) | $23.16B(+1.2%) |
| Dec 2009 | - | $22.87B(-3.4%) |
| Sep 2009 | - | $23.68B(+16.5%) |
| Mar 2009 | $20.37B(-19.6%) | $20.32B(-10.9%) |
| Dec 2008 | - | $22.80B |
| Mar 2008 | $25.35B(+30.3%) | - |
| Mar 2007 | $19.46B(+11.3%) | - |
| Mar 2006 | $17.48B(+1.9%) | - |
| Mar 2005 | $17.16B(+10.4%) | - |
| Mar 2004 | $15.54B(+32.3%) | - |
| Mar 2003 | $11.74B(+32.4%) | - |
| Mar 2002 | $8.87B(+12.4%) | - |
| Mar 2001 | $7.89B(-9.7%) | - |
| Mar 2000 | $8.74B(+32.8%) | - |
| Mar 1999 | $6.58B(+21.0%) | - |
| Mar 1998 | $5.44B(+1.9%) | - |
| Mar 1997 | $5.34B(-5.5%) | - |
| Mar 1996 | $5.65B(-12.3%) | - |
| Mar 1995 | $6.44B(+28.1%) | - |
| Mar 1994 | $5.03B(+20.1%) | - |
| Mar 1993 | $4.19B(+25.4%) | - |
| Mar 1992 | $3.34B(+12.1%) | - |
| Mar 1991 | $2.98B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual retained earnings?
- What is the all time high annual retained earnings for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual retained earnings year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly retained earnings?
- What is the all time high quarterly retained earnings for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly retained earnings year-on-year change?
What is Takeda Pharmaceutical Company Limited annual retained earnings?
The current annual retained earnings of TAK is $7.94B
What is the all time high annual retained earnings for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual retained earnings is $27.41B
What is Takeda Pharmaceutical Company Limited annual retained earnings year-on-year change?
Over the past year, TAK annual retained earnings has changed by -$1.25B (-13.61%)
What is Takeda Pharmaceutical Company Limited quarterly retained earnings?
The current quarterly retained earnings of TAK is $8.00B
What is the all time high quarterly retained earnings for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly retained earnings is $30.45B
What is Takeda Pharmaceutical Company Limited quarterly retained earnings year-on-year change?
Over the past year, TAK quarterly retained earnings has changed by -$313.53M (-3.77%)